跳至主要内容
临床试验/CTRI/2025/02/080121
CTRI/2025/02/080121尚未招募3 期

A randomized controlled trial to compare between tramadol and diclofenac for achieving analgesia in patients of acute pancreatitis.

IPGMER AND SSKM1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2025年2月24日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
74
试验地点
1
主要终点
To measure the difference in efficacy of tramadol and diclofenac in pain relief in patients of acute pancreatitis.

研究概览

简要总结

This is a randomized controlled trial that will be conducted in admitted patients in Division of Gastroenterology School of Digestive and Liver disease of Institute of Post Graduate Medical Education and Research kolkata India. This study will be double blind parallel group 1 :1 allocation randomized controlled trial  that will be conducted from February 2025 to October 2026. After  inclusion and exclusion criteria are met ,patient are admitted in indoor. They are randomized to receive either medication A/B (diclofenac/tramadol). Study medication A or B will be decided and fixed as either diclofenac or tramadol  by independent doctor not associated with the study. Patient will receive  injection diclofenac or injection tramadol diluted in 100 ml normal saline and run every 8 hourly over 30 minute for 24 hours. Fentanyl will be used as rescue analgesia in both the groups and will be delivered through patient controlled analgesia pump. The demand dose of fentanyl is 0.3 microgram per kg and lock out interval 15 minutes. So after  a bolus dose taken by patient ,the next dose will be delivered after 15 minutes. Patient will be instructed to press the button of the pump when he feels pain. Those delivered dose will be counted  by the pump as effective dose and those not delivered will be counted by ineffective dose. If the total number of ineffective dose  is 24 or more at the end of 24 hours then the study medication will be crossed over and the cross over drug will be given for 2 dose 8 hr apart. Thus the study ends at 24 hours if there is no cross over and at 40 hours if there is cross over. The total number of effective , ineffective demands, total dose of fentanyl, pain free time will be measured. Pain will also be recorded on visual analogue scale and noted at starting, 4 hours, 12 hours,18 hours,24 hours and 6 hourly if cross over happens. Assessment of pain relief will be compared in terms of 1. total dose of fentanyl, 2. duration of time measured when patient did not require rescue analgesia,3 total number of effective and ineffective demands. Also pain by Visual analogue score will be compared. Need of crossover will be recorded. For adverse events comparisons any new change in haematological or biochemical parameter will be documented. Particularly following adverse events will be noted -nausea and vomiting, paralytic ileus, altered sensorium, respiratory depression, gastrointestinal bleeding, and acute kidney injury. All findings will be expressed in text, tables and graphs. Data will be presented as mean (s.d.) or median ( IQR) as appropriate. The Student t test shall be used for continuous variables. The Chi Square test or Fisher exact test  for a 2 tailed p value shall be used to compare the qualitative data between two groups. The Wilcoxon rank sum test will be used for comparing non parametric variables with in a group. Mann - Whitney U test will be used for comparing non parametric variables between the groups. An intention to treat analysis will be performed to compare the data. Two tailed p value of less than 0.005 will be called significant.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • Patients of acute pancreatitis diagnosed as per revised Atlanta classification with two out of the following three points
  • abdominal pain consistent with acute pancreatitis
  • Serum lipase or amylase activity at least three times greater than upper limit of normal
  • Characteristics imaging finding on trans abdominal ultrasound or contrast enhanced computed tomography of abdomen or magnetic resonance imaging of pancreas.
  • The patient diagnosed as acute pancreatitis should be 1.present with in 7 day of pain onset 2.presents with pain abdomen with visual analogue score 3 or more and
  • normal sensorium as defined by Glasgow coma score 15.

排除标准

  • Age less than 18 and more than
  • Patient with evidence of chronic pancreatitis.
  • Patient with shock requiring vasopressor.
  • Patient with respiratory failure requiring mechanical ventilation.
  • Patient with serum creatinine more than equal to 1.5 mg per dl.
  • Patient with coronary artery disease.
  • Patient with altered sensorium with Glasgow coma scale less than
  • Patient refuses to give consent.

结局指标

主要结局

To measure the difference in efficacy of tramadol and diclofenac in pain relief in patients of acute pancreatitis.

时间窗: 40 hours and 3 days of follow up

次要结局

  • To measure the difference in the adverse events between the diclofenac and tramadol group.

研究者

发起方
IPGMER AND SSKM
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

DR ARUNAVA SARKAR

IPGMER AND SSKM

研究点 (1)

Loading locations...

相似试验

Comparison between tramadol and diclofenac for pain... | 临床试验